Signs of Glucagon Resistance After a 2-Week Hypercaloric Diet Intervention

J Clin Endocrinol Metab. 2024 Mar 15;109(4):955-967. doi: 10.1210/clinem/dgad666.

Abstract

Context: Hyperglucagonemia is observed in individuals with obesity and contributes to the hyperglycemia of patients with type 2 diabetes. Hyperglucagonemia may develop due to steatosis-induced hepatic glucagon resistance resulting in impaired hepatic amino acid turnover and ensuing elevations of circulating glucagonotropic amino acids.

Objective: We evaluated whether glucagon resistance could be induced in healthy individuals by a hypercaloric diet intervention designed to increase hepatic fat content.

Methods: We recruited 20 healthy male individuals to follow a hypercaloric diet and a sedentary lifestyle for 2 weeks. Amino acid concentrations in response to infusion of glucagon were assessed during a pancreatic clamp with somatostatin and basal insulin. The reversibility of any metabolic changes was assessed 8 weeks after the intervention. Hepatic steatosis was assessed by magnetic resonance spectroscopy.

Results: The intervention led to increased hepatic fat content (382% [206%; 705%], P < .01). Glucagon infusion led to a decrease in the concentration of total amino acids on all experimental days, but the percentage change in total amino acids was reduced (-2.5% ± 0.5% vs -0.2% ± 0.7%, P = .015) and the average slope of the decline in the total amino acid concentration was less steep (-2.0 ± 1.2 vs -1.2 ± 0.3 μM/min, P = .016) after the intervention compared to baseline. The changes were normalized at follow-up.

Conclusion: Our results indicate that short-term unhealthy behavior, which increases hepatic fat content, causes a reversible resistance to the effect of glucagon on amino acid concentrations in healthy individuals, which may explain the hyperglucagonemia associated with obesity and diabetes.

Keywords: amino acids; glucagon resistance; hepatic steatosis; hypercaloric diet; liver-alpha cell axis; nonalcoholic fatty liver disease.

MeSH terms

  • Amino Acids / metabolism
  • Diabetes Mellitus, Type 2* / metabolism
  • Diet
  • Fatty Liver* / metabolism
  • Glucagon / metabolism
  • Humans
  • Insulin / metabolism
  • Liver / metabolism
  • Male
  • Obesity / complications
  • Obesity / metabolism

Substances

  • Glucagon
  • Amino Acids
  • Insulin